LH and DGX Related Headlines
Go Back- Mizuho comments on DGX and LH post CMS on Monday
- Evercore comments on LH and DGX post CMS on Monday
- CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk
- Barclays: Life science insiders sold $187M in stock during first quarter


